Stifel Financial’s Kite Pharma, Inc. KITE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-3,380
Closed -$609K 2781
2017
Q3
$609K Sell
3,380
-22,047
-87% -$3.07M ﹤0.01% 1766
2017
Q2
$2.63M Buy
25,427
+17,350
+215% +$1.42M 0.01% 987
2017
Q1
$637K Sell
8,077
-25,431
-76% -$1.57M ﹤0.01% 1679
2016
Q4
$1.48M Buy
33,508
+14,546
+77% +$714K 0.01% 1177
2016
Q3
$1.06M Buy
18,962
+13,586
+253% +$757K ﹤0.01% 1296
2016
Q2
$269K Sell
5,376
-434
-7% -$21.3K ﹤0.01% 2100
2016
Q1
$267K Sell
5,810
-6,282
-52% -$304K ﹤0.01% 1876
2015
Q4
$745K Buy
12,092
+3,519
+41% +$248K ﹤0.01% 1447
2015
Q3
$477K Sell
8,573
-36,340
-81% -$2.29M ﹤0.01% 1586
2015
Q2
$2.74M Sell
44,913
-69,419
-61% -$3.96M 0.01% 829
2015
Q1
$6.59M Buy
114,332
+23,741
+26% +$1.59M 0.04% 520
2014
Q4
$8.13M Buy
+90,591
New +$3.81M 0.05% 454

Stifel Financial's KITE Position: Q4 2017 in Review

Stifel Financial sold out of Kite Pharma, Inc. (KITE) in Q4 2017, closing a stake of 3,380 shares — an estimated $609K sold.

Stifel Financial first reported a position in KITE in Q4 2014 and held it in 12 quarters. The position peaked at $8.13M in Q4 2014. 0 funds tracked by Wall St. Rank hold KITE as of Q4 2017.

  • Stifel Financial reported no remaining Kite Pharma, Inc. position as of Q4 2017 after selling out during the quarter.
  • Stifel Financial sold 3,380 Kite Pharma, Inc. shares in Q4 2017, an estimated $609K.
  • Stifel Financial first reported a position in Kite Pharma, Inc. in Q4 2014 and held it in 12 quarters.
  • Stifel Financial's Kite Pharma, Inc. position peaked at $8.13M in Q4 2014.
  • 0 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q4 2017.

Based on Stifel Financial's 13F filing for Q4 2017, filed 14 Feb 2018.